CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 21, 2017--
Catabasis
Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage
biopharmaceutical company, today announced that Jill C. Milne, Ph.D.,
Chief Executive Officer, will present an overview of the company in a
fireside chat at the 29th Annual Piper Jaffray Healthcare
Conference on Tuesday, November 28, 2017 at 2:00pm ET at the Lotte New
York Palace in New York, NY.
About Catabasis
At Catabasis Pharmaceuticals, our mission is
to bring hope and life-changing therapies to patients and their
families. Our SMART (Safely Metabolized And Rationally Targeted) Linker
drug discovery platform enables us to engineer molecules that
simultaneously modulate multiple targets in a disease. We are applying
our SMART LinkerSM platform to build an internal pipeline of
product candidates for rare diseases and plan to pursue partnerships to
develop additional product candidates. For more information on the
Company's drug discovery platform and pipeline of drug candidates,
please visit www.catabasis.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171121005086/en/
Source: Catabasis Pharmaceuticals, Inc.
Investor and Media Contact
Catabasis
Pharmaceuticals, Inc.
Andrea Matthews, 617-349-1971
amatthews@catabasis.com
